BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ćulafić Đ, Štulić M, Obrenović R, Miletić D, Mijač D, Stojković M, Jovanović M, Ćulafić M. Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis. World J Gastroenterol 2014; 20(21): 6573-6579 [PMID: 24914379 DOI: 10.3748/wjg.v20.i21.6573]
URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6573.htm
Number Citing Articles
1
Jianchun Lu, Lin Lin, Chunyan Ye, Qian Tao, Manman Cui, Shuqin Zheng, Dongmei Zhu, Longgen Liu, Yuan Xue. Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver FailureAnnals of Hepatology 2019; 18(1): 155 doi: 10.5604/01.3001.0012.7907
2
Nader Salari, Mohsen Kazeminia, Kamran Mansouri, Amin Hosseinian-Far, Masoud Mohammadi. The Activity and Polymorphism of the PON1 in Patients with Chronic Liver Disease: a Systematic Review and Meta-analysisJournal of Gastrointestinal Cancer 2022; 53(3): 745 doi: 10.1007/s12029-021-00699-7
3
Dong Wang, Jia-Fu Feng, An-Qun Wang, Yu-Wei Yang, Yun-Shuang Liu. Role of Cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patientsMedicine 2017; 96(20): e6949 doi: 10.1097/MD.0000000000006949
4
Erman Cilsal, Ayse Selcan Koc. Renal resistive index significantly increased in hypertensive children and it is independently related to the pulse pressure and left ventricular mass indexClinical and Experimental Hypertension 2019; 41(7): 607 doi: 10.1080/10641963.2018.1523920
5
C. Mousseaux, A. Bouguerba, S. Ayed, J. Barchasz, M. Boukari, D. Goldgran-Toledano, C. Bornstain, F. Vincent. Appréciation du débit de filtration glomérulaire et de la dysfonction rénale chez le cirrhotiqueRéanimation 2016; 25(S3): 137 doi: 10.1007/s13546-016-1215-2
6
Serap Çuhadar. Biomarkers in Kidney Disease2015; : 1 doi: 10.1007/978-94-007-7743-9_20-1
7
Pierpaolo Di Nicolò, Antonio Granata. Renal intraparenchymal resistive index: the ultrasonographic answer to many clinical questionsJournal of Nephrology 2019; 32(4): 527 doi: 10.1007/s40620-018-00567-x
8
Milos Stulic, Djordje Culafic, Radmila Obrenovic, Goran Jankovic, Tamara Alempijevic, Milica Lalosevic, Natasa Dostanic, Sandra Kovacevic, Milica Culafic. The Clinical Importance of Cystatin C and Hepatic Artery Resistive Index in Liver CirrhosisMedicina 2018; 54(3): 37 doi: 10.3390/medicina54030037
9
Chidiogo Chukwunweike Onwuka, Oluwagbemiga Oluwole Ayoola, Olusegun Adekanle, Olusola Comfort Famurewa, Ibukun Anuoluwa Abidoye. Renal arterial resistance index among subjects with liver cirrhosis in a Nigerian populationJournal of Clinical Ultrasound 2021; 49(6): 538 doi: 10.1002/jcu.22985
10
G A Siregar, M Gurning. Renal dysfunction in liver cirrhosis and its correlation with Child-Pugh score and MELD scoreIOP Conference Series: Earth and Environmental Science 2018; 125: 012214 doi: 10.1088/1755-1315/125/1/012214
11
Carlos G. Musso, Paola Casciato, Juan Macías‐Nuñez, Ramón Ardanuy, Henry Gonzalez‐Torres, Gustavo Aroca‐Martinez, Cristina Torres‐Caro, Adrian Narvaez, Mariano Bonifacio, Marlene Padilla, Adrian Gadano. Chronic kidney disease (CKD) and chronic kidney insufficiency (CKI) diagnosing equation in cirrhotic patientsNephrology 2022; 27(8): 658 doi: 10.1111/nep.14075
12
Serap Çuhadar. Biomarkers in Kidney Disease2016; : 445 doi: 10.1007/978-94-007-7699-9_20
13
Mahmoud Omar, Wael Abdel-Razek, Gamal Abo-Raia, Medhat Assem, Gasser El-Azab. Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver CirrhosisInternational Journal of Hepatology 2015; 2015: 1 doi: 10.1155/2015/309042
14
R. R. Nagimullin, F. A. Shipulin, A. Zh. Bayalieva. HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARECreative surgery and oncology 2018; 8(1): 76 doi: 10.24060/2076-3093-2018-8-1-76-83
15
Ahmed M. Abd El Wahab, Abeer Awadeen, Mostafa M. Mansour, Rasha Shemies. The diagnostic and prognostic utility of serum cystatin C and angiopoietin 2 in patients with liver cirrhosis complicated by acute kidney injuryTherapeutic Apheresis and Dialysis 2023; 27(3): 419 doi: 10.1111/1744-9987.13936